These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
95 related items for PubMed ID: 5396508
1. Pharmacodynamics of phosphonomycin after oral administration in man. Foltz EL, Wallick H, Rosenblum C. Antimicrob Agents Chemother (Bethesda); 1969; 9():322-6. PubMed ID: 5396508 [No Abstract] [Full Text] [Related]
2. Pharmacodynamics of phosphonomycin after intravenous administration in man. Foltz EL, Wallick H. Antimicrob Agents Chemother (Bethesda); 1969; 9():316-21. PubMed ID: 5396507 [No Abstract] [Full Text] [Related]
3. Clinical pharmacology and in vitro activity of phosphonomycin. Kestle DG, Kirby WM. Antimicrob Agents Chemother (Bethesda); 1969; 9():332-7. PubMed ID: 5396510 [No Abstract] [Full Text] [Related]
4. The oral absorption of doxycycline by man. von Wittenau MS. Int Z Klin Pharmakol Ther Toxikol; 1969 Jan; 2(1):52-5. PubMed ID: 4979040 [No Abstract] [Full Text] [Related]
5. Phosphonomycin. V. Evaluation in mice. Miller AK, Frost BM, Valiant ME, Kropp H, Hendlin D. Antimicrob Agents Chemother (Bethesda); 1969 Jan; 9():310-5. PubMed ID: 5396506 [No Abstract] [Full Text] [Related]
12. [Resorption of orally administered antibiotics and chemotherapeutic drugs and their effect. Part 1]. Guggenbichler J. Padiatr Padol; 1981 Jul 12; 16(2):273-86. PubMed ID: 7243336 [Abstract] [Full Text] [Related]
17. Studies on absorption of leucomycin from intestinal tract. Hoshino Y. J Antibiot (Tokyo); 1967 Nov 12; 20(6):361-8. PubMed ID: 5631370 [No Abstract] [Full Text] [Related]
18. Phosphonomycin. IV. Susceptibility testing method and survey. Zimmerman SB, Stapley EO, Wallick H, Baldwin R. Antimicrob Agents Chemother (Bethesda); 1969 Nov 12; 9():303-9. PubMed ID: 5396505 [No Abstract] [Full Text] [Related]
19. Dose-independent pharmacokinetics of clindamycin after intravenous and oral administration to rats: contribution of gastric first-pass effect to low bioavailability. Yang SH, Lee MG. Int J Pharm; 2007 Mar 06; 332(1-2):17-23. PubMed ID: 17157458 [Abstract] [Full Text] [Related]